Citigroup’s Vera Therapeutics VERA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10.1M Buy
249,969
+75,714
+43% +$3.26M 0.01% 1472
2025
Q4
$8.82M Buy
174,255
+165,121
+1,808% +$5.86M 0.01% 1634
2025
Q3
$265K Sell
9,134
-69,403
-88% -$1.6M ﹤0.01% 3877
2025
Q2
$1.85M Sell
78,537
-63,714
-45% -$1.43M ﹤0.01% 2715
2025
Q1
$3.42M Buy
142,251
+24,767
+21% +$796K ﹤0.01% 2251
2024
Q4
$4.97M Buy
117,484
+88,080
+300% +$3.9M ﹤0.01% 1965
2024
Q3
$1.3M Buy
29,404
+8,122
+38% +$308K ﹤0.01% 3039
2024
Q2
$770K Sell
21,282
-131,286
-86% -$5.21M ﹤0.01% 3087
2024
Q1
$6.58M Buy
152,568
+82,263
+117% +$2.93M 0.01% 1525
2023
Q4
$1.08M Buy
70,305
+12,915
+23% +$164K ﹤0.01% 2759
2023
Q3
$787K Buy
57,390
+47,322
+470% +$812K ﹤0.01% 2701
2023
Q2
$162K Buy
+10,068
New +$90.9K ﹤0.01% 3997
2023
Q1
Sell
-467
Closed -$9.04K 5897
2022
Q4
$9.04K Sell
467
-783
-63% -$14.2K ﹤0.01% 4872
2022
Q3
$27K Sell
1,250
-9,980
-89% -$187K ﹤0.01% 4633
2022
Q2
$153K Buy
11,230
+335
+3% +$5.85K ﹤0.01% 3992
2022
Q1
$256K Buy
10,895
+8,238
+310% +$177K ﹤0.01% 3928
2021
Q4
$71K Buy
2,657
+1,847
+228% +$40.9K ﹤0.01% 4912
2021
Q3
$14K Buy
+810
New +$14.5K ﹤0.01% 5383

Other funds holding VERA